NEW YORK & LYON, France–(BUSINESS WIRE)–The MEDICREA Group (Alternext Paris: FR0004178572 – ALMED), a company that specializes in the development of innovative spinal implants for the treatment of spinal pathologies, today announced the U.S. launch of LigaPASS® 2.0 generation, MEDICREA’s band connector technology for

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone